Amoscanate

Amoscanate

SCHEMBL159478

O=[N+]([O-])c1ccc(Nc2ccc(N=C=S)cc2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.56
ALOX12 P18054 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ALDH1A1 P00352 3/20 0.46
RECQL P46063 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CXCR2 P25025 1/20 0.45
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
KIF11 P52732 1/20 0.43
MAPT P10636 7/20 0.43
MAPK1 P28482 4/20 0.43
NPSR1 Q6W5P4 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206480 0.89 PLAU (0.50) ALDH1A1HSD17B10MEN1KMT2ARAB9A
SCHEMBL11695391 0.85 HPGD (0.47) HPGDALOX12L3MBTL1ALDH1A1MEN1
SCHEMBL11221931 0.85 HPGD (0.58) HPGDALOX12L3MBTL1ALDH1A1RECQL
SCHEMBL11696478 0.83 MAPT (0.63) L3MBTL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL11712753 0.83 MEN1 (0.63) ALOX12ALDH1A1MEN1KMT2ARAB9A
SCHEMBL1848797 0.82 MIF (0.54) HPGDALOX12L3MBTL1ALDH1A1RECQL
Nitroscanate SCHEMBL381451 0.81 HSPB1 (0.56) L3MBTL1ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL10622842 0.80 MAPT (0.54) HPGDALDH1A1HSD17B10MEN1KMT2A
SCHEMBL18289621 0.80 HPGD (0.83) HPGDALOX12L3MBTL1ALDH1A1RECQL
SCHEMBL4957626 0.80 HPGD (0.83) HPGDALOX12L3MBTL1ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4586826-A1 FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL In the Bowl Animal Health, Inc. (US) 2025-07-23 EP claimed
WO-2024059837-A1 FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL IN THE BOWL ANIMAL HEALTH, INC. (US) 2024-03-21 WO claimed
EP-3078664-B1 ANTIPARASITIC DIHYDROAZOLE COMPOSITIONS MERIAL INC (US) 2019-02-20 EP claimed
CN-107260654-A It is a kind of to prepare the method that Thermo-sensitive replaces stratiform insoluble drug release composite 四川大学 2017-10-20 CN claimed
CN-106344496-A Preparation method of macromolecular laminar drug-loaded hydrogel with controllable drug distribution 四川大学 2017-01-25 CN claimed
CN-106344497-A Preparation method of macromolecular multi-layered hydrogel drug sustained-release material 四川大学 2017-01-25 CN claimed
CN-103735490-B A kind of method preparing Thermosensitive Material Used for Controlled Releasing of Medicine SICHUAN UNIVERSITY (CN) 2016-02-10 CN claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20140371179-A1 Methods and Compositions for Treating Esophageal Diseases PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (US) 2014-12-18 US claimed
US-20140348787-A1 Methods and Compositions for Treating Ear Infections PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (US) 2014-11-27 US claimed
CN-103735490-A Method for preparing medicament sustained-release material UNIV SICHUAN 2014-04-23 CN claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
US-4117156-A 4-(4-NITROANILINO)-PHENYLISOTHIOCYANATE CIBA-GEIGY AG (CH) 1978-09-26 US claimed